Toggle light / dark theme

Dive into the subatomic world, into the heart of protons or neutrons, and you’ll find elementary particles known as quarks. Measuring the mass of these quarks can be challenging, but new results from the CMS collaboration reveal for the first time how the mass of the top quark – the heaviest of six types of quarks – varies depending on the energy scale used to measure the particle.

The theory of quantum chromodynamics, a component of the Standard Model, predicts this energy-scale variation, known as running, for the masses of all quarks and for the strong force acting between them. Observing the running masses of quarks can therefore provide a way of testing quantum chromodynamics and the Standard Model.

Experiments at CERN and other laboratories have already measured the running masses of the bottom and charm quarks, the second and third heaviest quarks, and the results were in agreement with quantum chromodynamics. Now, the CMS collaboration has used data from high-energy proton–proton collisions at the Large Hadron Collider to chase out the running mass of the top quark.

We recently had the opportunity to interview Dr. Amutha Boominathan from the SENS Research Foundation, at the Ending Age-Related Diseases 2019 conference about her research on mitochondrial repair therapies, the value of animal models, and her views on the future of aging research.

Dr. Amutha Boominathan received both her MSc and her PhD in Biochemistry from the University of Pune and the National Chemical Laboratory in India, respectively. She went on to do postdoctoral work in the U.S. relating to mitochondrial biogenesis at U. Penn and Rutgers University. She has extensively studied mechanisms of fusion and fission in mitochondria, Fe-S cluster biosynthesis, and protein import into mitochondria as part of her postdoctoral fellowship with the American Heart Association.

Currently, Amutha leads the MitoSENS program at SENS Research Foundation in Mountain view, California. Her research group is focusing on understanding mitochondrial DNA (mtDNA) mutations and restoring lost functionality as a result of these mutations by way of the allotopic expression of mitochondrial genes. Inherited mtDNA mutations can result in severe and debilitating diseases, such as NARP, Leigh’s syndrome and MELAS. Even in otherwise healthy individuals, mtDNA mutations accumulate with age. The MitoSENS team has already succeeded in stably expressing the ATP8 gene using their method and is looking forward to tackling each of the 13 mitochondrial protein genes in the coming years. Its goal is to develop safe and effective gene therapies for mitochondrial dysfunction.

My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself. I read the books and do all the research and share my findings with you!

This video is me (Brent Nally) interviewing Transhumanist Party US Presidential Candidate Ben Zion on October 3, 2019 at RAADFest at the Westgate Hotel & Casino.

https://www.raadfest.com

Ben’s Facebook: https://m.facebook.com/profile.php?id=100010498697361

Live forever smile


“Success Is A Choice” — Motivational Song — DJ Clayvis.

For more information about scheduling Clay Clark to speak to your organization visit: www.makeyourlifeepic.com or call for more information today at 918−851−6920.

www.MakeYourLifeEpic.com — 918−851−6920